Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients

被引:28
|
作者
Baptista, Joao Pedro [1 ]
Martins, Paulo Jorge [1 ]
Marques, Margarida [2 ]
Pimentel, Jorge Manuel [1 ]
机构
[1] Ctr Hosp & Univ Coimbra CHUC, Dept Intens Care, Coimbra, Portugal
[2] Ctr Hosp & Univ Coimbra CHUC, Dept Stat, Coimbra, Portugal
关键词
critical care; epidemiology; augmented renal clearance; risk; creatinine clearance; antibiotics; CREATININE CLEARANCE; ICU; HYPERFILTRATION; WEIGHT;
D O I
10.1177/0885066618809688
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Critically ill patients show a high, albeit variable, prevalence of augmented renal clearance (ARC). This condition has relevant consequences on the elimination of hydrophilic drugs. Knowledge of risk factors for ARC helps in the early identification of ARC. The aims of this study were evaluation of (1) risk factors for ARC and (2) the prevalence of ARC in critically ill patients over a period of 1 year. Methods: A retrospective cohort study was performed for all consecutive patients admitted to our intensive care unit (ICU). Augmented renal clearance was defined by a creatinine clearance >= 130 mL/min/1.73 m(2). "Patient with ARC" was defined as a patient with a median of creatinine clearance >= 130 mL/min/1.73 m(2)over the period of admission. Four variables were tested, Simplified Acute Physiology Score II (SAPS II), male gender, age, and trauma as cause for ICU admission. An analysis (patient based and clearance based) was performed with logistic regression. Results: Of 475 patients, 446 were included in this study, contributing to 454 ICU admissions and 5586 8-hour creatinine clearance (8h-CLCR). Overall, the prevalence of patients with ARC was 24.9% (n = 113). In a subset of patients with normal serum creatinine levels, the prevalence was 43.0% (n = 104). Of the set of all 8h-CL(CR)measurements, 25.4% (1418) showed ARC. In the patient-based analysis, the adjusted odds ratio was: 2.0 (confidence interval [CI]:1.1-3.7;P< .05), 0.93 (CI: 0.91-0.94;P< .01), 2.7 (CI: 1.4-5.3;P< .01), and 0.98 (CI: 0.96 -1.01;P= .15), respectively, for trauma, age, male sex, and SAPS II. In the clearance-based analysis, the adjusted odds ratio were 1.7 (CI: 1.4-1.9;P< .01), 0.94 (CI: 0.932-0.942;P< .01), and 2.9 (CI: 2.4-3.4;P< .01), respectively, for trauma, age, and male sex. Conclusions: Trauma, young age, and male sex were independent risk factors for ARC. This condition occurs in a considerable proportion of critical care patients, which was particularly prevalent in patients without evidence of renal dysfunction.
引用
收藏
页码:1044 / 1052
页数:9
相关论文
共 50 条
  • [41] Therapeutic Drug Monitoring In A Critically Ill Patient With Augmented Renal Clearance
    Lowther, G.
    Cope, J.
    Klinker, K.
    Shychuk, A.
    Fakih, H.
    Hadigal, S.
    Ataya, A.
    Alnuaimat, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [42] Augmented Renal Clearance in the Critically Ill: How to Assess Kidney Function
    Grootaert, Veerle
    Willems, Ludo
    Debaveye, Yves
    Meyfroidt, Geert
    Spriet, Isabel
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 952 - 959
  • [43] Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children
    Evelyn Dhont
    Tatjana Van Der Heggen
    Evelien Snauwaert
    Jef Willems
    Siska Croubels
    Joris Delanghe
    Jan J. De Waele
    Roos Colman
    Johan Vande Walle
    Peter De Paepe
    Pieter A. De Cock
    Pediatric Nephrology, 2024, 39 : 1607 - 1616
  • [44] Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children
    Dhont, Evelyn
    Van der Heggen, Tatjana
    Snauwaert, Evelien
    Willems, Jef
    Croubels, Siska
    Delanghe, Joris
    De Waele, Jan J.
    Colman, Roos
    Vande Walle, Johan
    De Paepe, Peter
    De Cock, Pieter A.
    PEDIATRIC NEPHROLOGY, 2024, 39 (05) : 1607 - 1616
  • [45] PREVALENCE AND RISK FACTORS FOR DELIRIUM IN CRITICALLY ILL PATIENTS IN JAPAN
    Nakahara, Takashi
    Tsurutra, Ryosuke
    Miyauchi, Takashi
    Kutsuna, Satoshi
    Ogino, Yasuaki
    Yamamoto, Takahiro
    Kawamura, Yoshikatsu
    Kasaoka, Shunji
    Maekawa, Tsuyoshi
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A183 - A183
  • [46] Augmented renal clearance: a retrospective, cohort study of urinary creatinine clearance in critically ill patients in the United Kingdom
    Johnston, Brian W.
    Perry, David
    Habgood, Martyn
    Joshi, Miland
    Krige, Anton
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (05)
  • [47] Augmented renal clearance in non-critically ill abdominal and trauma surgery patients is an underestimated phenomenon: A point prevalence study
    Declercq, Peter
    Nijs, Stefaan
    D'Hoore, Andre
    Van Wijngaerden, Eric
    Wolthuis, Albert
    van Overstraeten, Anthony de Buck
    Wauters, Joost
    Spriet, Isabel
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2016, 81 (03): : 468 - 477
  • [48] Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance
    Agathe Béranger
    Sihem Benaboud
    Saïk Urien
    Florence Moulin
    Emmanuelle Bille
    Fabrice Lesage
    Yi Zheng
    Mathieu Genuini
    Inès Gana
    Sylvain Renolleau
    Déborah Hirt
    Jean-Marc Tréluyer
    Mehdi Oualha
    Clinical Pharmacokinetics, 2019, 58 : 223 - 233
  • [49] Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance Predictor
    Gijsen, Matthias
    Huang, Chao-Yuan
    Flechet, Marine
    Van Daele, Ruth
    Declercq, Peter
    Debaveye, Yves
    Meersseman, Philippe
    Meyfroidt, Geert
    Wauters, Joost
    Spriet, Isabel
    CRITICAL CARE MEDICINE, 2020, 48 (12) : E1260 - E1268
  • [50] External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 Patients
    Huang, Chao-Yuan
    Guiza, Fabian
    Gijsen, Matthias
    Spriet, Isabel
    Dauwe, Dieter
    Debaveye, Yves
    Peetermans, Marijke
    Wauters, Joost
    Van den Berghe, Greet
    Meyfroidt, Geert
    De Vlieger, Greet
    ANTIBIOTICS-BASEL, 2023, 12 (04):